Beam Therapeutics Inc (BEAM)
Healthcare
Biotechnology
25.50 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Beam Therapeutics Inc (BEAM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -129 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -85 | -90 | 135 | -100 | -83 | -88 | -76 | -104 | -76 | -81 | -83 | -129 | -370 | |
| 4.8 | 5.2 | 5.4 | 5.4 | 5.6 | 5.5 | 15 | 5.5 | 5.5 | 5.6 | 5.7 | 5.6 | 22 | |
| 26 | 26 | 23 | 29 | 32 | 30 | 30 | 27 | 24 | 23 | -74 | 19 | -7.6 | |
| 27 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -20 | -20 | -32 | -38 | -26 | -26 | -21 | -25 | 3.4 | -7.1 | -102 | -56 | -161 | |
| 16 | 7.9 | 3.6 | 2.4 | 2.0 | 1.6 | 3.0 | 3.1 | 3.1 | 5.0 | 3.7 | 2.2 | 14 | |
| -41 | -10 | 98 | -53 | 87 | 25 | 126 | -125 | -170 | 66 | 108 | 25 | 29 | |
| 108 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.6 | – | – | – | – | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 94 | 94 | |
| 108 | 37 | 34 | 2.9 | 0.1 | 1.3 | 3.4 | 473 | 1.1 | 1.7 | 1.9 | 97 | 101 | |
| -19 | -63 | 267 | -150 | 4.6 | -62 | 53 | 244 | -246 | -14 | 27 | -6.7 | -240 | |
| -101 | -98 | 131 | -102 | -85 | -90 | -79 | -107 | -80 | -86 | -87 | -131 | -384 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.